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Abstract 
Accurate measurement of breast tumour size determines staging and prognosis. Discrepancies amongst clinical examination (CE), 
ultrasonography (USG), mammography, pathological examination (PE) and magnetic resonance imaging have been reported. However, 
few studies have evaluated changes in breast tumour size from the operating table to the laboratory. 
Objectives and methods: A prospective study was designed to assess the intra-operative (IO) tumour size in 29 patients of breast 
cancer presenting to a tertiary care centre in Delhi and to compare it with CE, USG and PE. 
Observations and results: Twenty-nine patients (mean age: 47 years), presenting with invasive duct carcinoma (stage IIIA: 31%, stage 
IIB: 28%), were included in the study. Comparison with mean IO (4.2 cm) revealed that both USG and PE underestimated tumour size by 
a mean of 0.35 cm (8.4%) and 0.45 cm (10.7%), respectively, in most patients. CE tended to overestimate size by 0.82 cm (19.8%). All 
three modalities showed statistically significant correlation with IO (maximum Pearson's correlation coefficient for PE=0.937, p<0.001; 
R
2=0.877, maximum for PE). Two-way analysis of variance revealed mean difference in size to be statistically significant (p=0.000) only 
between CE and IO.  
Discussion: Formalin processing causes changes in tumour dimensions in the breast, causing reduction in tumour size. It may also 
have a bearing on the assessment of surgical margins in breast conservation surgery. Immediate post-operative measurement of the 
specimen is ideal. Protocols for specimen fixation should be standardized. 
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Background 
Tumour size is an independent prognostic factor in breast 
carcinoma and is a good predictor of lymph node metastases. 
Change in tumour size, as a response to chemotherapy, is also 
an independent predictor of disease-free survival [1,2]. The 
measurement of tumour size should be accurate as even small 
discrepancies can affect staging and treatment. The various 
techniques to assess tumour size are clinical examination (CE), 
mammography (MG), ultrasonography (USG), magnetic 
resonance imaging and pathologic examination (PE). The last is 
still considered the blueprint for pathological/final staging and 
for formulation of the treatment plan. 
It is known that there is considerable discrepancy in size after 
formalin processing in many cancers. Uterine, arterial, 
colorectal, lung and prostate have all been shown to undergo 
shrinkage in one or more dimensions, and even volume [3–7]. 
In breast cancer, variation has been reported between imaging 
modalities (USG, MG), PE and CE [8–10]. There are no 
guidelines regarding the state of the specimen to be taken as 
the standard for staging, that is fresh or fixed. The three-
dimensional measurements are most easily and accurately 
obtained from the fresh gross specimen. [7,11], but constraints 
of time and resources compel most laboratories to obtain the 
specimen after formalin fixation. Several reasons have been 
attributed to the disharmony in size between fresh and fixed 
specimens, including the use of formalin, the 'pancake 
phenomenon', compression during specimen radiography, 
tissue composition of the tumour, histological subtype [12–14]. 
The number of studies which have attempted to quantify the 
extent of this size discrepancy is surprisingly low [8,9,12,14] and 
even fewer have suggested corrections [9]. 
It is evident that studies addressing change in size should be 
organ-specific and account for tissue constitution. In this study, 
we intra-operatively (fresh state) measured the tumour size in 
patients with breast carcinoma and, considering it as the actual 
size, compared it to CE, USG and PE. We also attempted to 
predict the actual size from other measurements, using 
statistical formulae. 
 
 
Materials and methods 
A prospective study was carried out at the departments of 
surgery and pathology at the University College of Medical 
Sciences and Guru Teg Bahadur Hospital, Delhi, India from 
December 2006 to March 2008. Twenty-nine patients with a 
palpable breast lump diagnosed to be cancer, and planned for 
surgery, were enrolled for the study. Patients without a definite 
palpable breast lump, and those with inflammatory carcinoma, 
were excluded. 
A detailed history was obtained regarding patients' complaints 
and history of known risk factors such as family history of breast 
or ovarian cancer, previous breast disease, radiation exposure, 
reproductive details and drug therapy. 
Physical examination, chest x-ray, and USG of the breast for 
tumour size were carried out on all patients. The latter was done 
by an experienced radiologist to minimize operator variation. 
For patients with locally advanced disease, imaging for 
metastases in the form of a bone scan and USG of the 
abdomen was also performed. 
The accuracy in measurement was given maximum importance, 
and all the patients were seen by the same team (surgeon and 
radiologist) to avoid inter-observer variation. 
 
Clinical assessment of breast tumour size 
Clinically, the breast lump diameter was measured in two 
dimensions with Vernier's calipers, and tumour size was taken 
as the maximum diameter. 
 
Ultrasonographic assessment of tumour 
size 
A high-resolution linear array ultrasonic transducer with a 
frequency 7.5 MHz was used to assess the breasts mainly for 
tumour size, and for associated findings such as satellite 
nodules. Here, the measurements were taken in three 
dimensions, and the maximum diameter was recorded as 
tumour size. 
The assessment of the patient was completed as close to the 
proposed operation as feasible (2–3 days maximum), to avoid 
changes in the observations. 
 
Intra-operative assessment of tumour size 
After completing the proposed operation (modified radical 
mastectomy), the specimen was examined by the same 
surgeon who had performed the clinical examination. The 
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Table 1: Distribution of breast cancer patients by clinical and pathological stage 
specimen was sliced with the help of a scalpel, by cutting 
longitudinally from the posterior aspect into slices approximately 
2 cm thick. Maximum tumour diameter in three dimensions was 
measured to the nearest millimeter, and labelled as tumour size. 
To avoid problems in reporting due to the slicing affecting the 
deep-resected margin, tissue from deep within the tumour 
specimen was excised and labelled separately for 
histopathological examination. 
 
Pathological assessment 
The surgical specimen was fixed in formalin (for 14–20 hours) 
after intra-operative recording of tumour size, and sent for 
histological examination. The pathologist also recorded the size 
in three dimensions. 
Follow-up advice to patients was in accordance with the 
accepted protocol for breast carcinoma. 
 
Statistical analysis 
The maximum diameters measured by the different methods 
were compared, and the difference between individual data and 
the mean difference was calculated. Using two-way analysis of 
variance, taking size as a dependent variable, and the 
measurement method and subject as independent factors, post-
hoc pairwise comparison was done using Bonferroni adjustment 
for calculating significant value of the mean and the difference 
of means. 
Pearson's method was used to calculate correlation between 
maximum sizes measured by all four methods. Plotting a graph, 
and identifying the line of best fit by linear regression obtained 
correlation between intra-operative, clinical, ultrasonographic 
and pathological size. Significance value R
2 was derived from 
differences between the line of best fit and the line of equality. 
Using stepwise multiple regressions, taking the intra-operative 
measurement as dependent, and clinical, ultrasonographic and 
pathological measurements as independent predictors, an 
estimation of the intra-operative measurement was achieved 
using the other three methods. 
 
Observations and results 
A total of 29 patients were included in the study. The patients 
had a mean age of 47 years (range of 31–70 years). Most 
patients were 31–50 years of age. All patients had a lump in 
one breast. Three patients complained of associated pain and 
two of bloody nipple discharge. Only one patient had a history of 
associated risk factors, that is mastectomy for contralateral 
breast cancer two decades previously. Seventeen (58.6%) 
patients had a tumour located in the upper outer quadrant of the 
breast, while two had a large tumour occupying all four 
quadrants. 
The stage-wise distribution (clinical and pathological) of patients 
is shown in Table 1. None of the patients presented in clinical 
stage I. On pathological staging, most patients were in stage 
IIIA (31.02%) or stage IIB (27.6%). Twenty-four (82.76%)
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Figure 1: Correlation between intra-operative and pathological size. 
patients had invasive breast cancer of intermediate histological 
grade, that is Grade 2. 
 
Comparison between measurements of 
tumour size according to the different 
methods 
(1) Clinical versus intra-operative measurement of 
tumour size 
The mean diameter on clinical measurement was 4.98 cm and 
on intra-operative measurement was 4.16 cm. Hence, clinical 
examination tended to overestimate the tumour size by 19.76% 
(mean 0.82 cm). In 24 patients (82.75%), tumour size was 
overestimated by clinical examination, and in only five patients it 
was of the same value as intra-operative. 
(2) Ultrasonography versus intra-operative 
The mean maximum diameter (tumour size) by USG was 3.81 
cm, while intra-operative measurement was 4.16 cm. The mean 
difference was 0.35 cm, and an underestimation by USG of 
8.38%. Only in five patients did USG overestimate the size of 
the tumour. 
(3) Pathological versus intra-operative 
Pathological measurement tended to underestimate the tumour 
size. In seven specimens (24.14%), pathological measurement 
was the same value as intra-operative, but in 22 (75.86%), it 
underestimated the size (range 0–2.5 cm). The mean 
pathological size was 3.71 cm, as compared to 4.16 cm intra-
operatively (mean difference 0.45 cm, 10.7%). 
Using Pearson's correlation co-efficient, pathological 
measurement was found to have maximum correlation with 
intra-operative measurement (co-efficient 0.937; p<0.001). 
Clinical measurement and USG also showed good correlation 
(0.790; p<0.001 and 0.877; p<0.001, respectively.) 
Comparison between intra-operative and the other methods 
was also done by plotting a graph, and obtaining line of best fit 
by linear regression. Significance value R
2 was derived from 
differences between the line of best fit and the line of equality. 
This also showed that pathological measurement had maximum 
correlation with intra-operative size (Figure 1). 
Using two-way analysis of variance, taking size as the 
dependent variable and measurement method and subjects as 
independent factors, post-hoc pairwise comparison was done 
using Bonferroni adjustment (for multiple comparisons). It was 
seen that the mean difference in size was statistically significant
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(p=0.000) only for comparison between intra-operative and 
clinical measurement. 
 
Prediction of intra-operative measurement 
by other methods 
Using stepwise multiple regression taking intra-operative 
measurement as dependent, and clinical, USG and pathological 
measurement as independent predictors, the following 
equations were derived: 
(1)  Intra-operative size = 0.324 cm + (0.611 × pathological 
size) + (0.301 × clinical size) 
(2)  Intra-operative size = 0.447 cm + (0.731 × clinical size) 
Hence, by using the clinical and pathological tumour size, we 
can predict the intra-operative size. 
Discussion 
The demographic profile of our patients is similar to other Indian 
data [15–17]. Most of our patients present with locally advanced 
breast cancer, mainly due to socio-cultural reasons. For the 
same reasons, they also prefer to opt for mastectomy, as 
frequent follow-up from far-flung areas can be prohibitive. This 
could explain the performance of modified radical mastectomy 
in all the 29 patients. 
All the modalities used in our study have proven to be as 
accurate as suggested in the literature. Clinical examination 
was compared with pathological examination as early in 1983, 
and some 'adjustment' was attempted for skin and fat thickness, 
as it tends to result in overestimating the size [18]. CE has been 
found to be very accurate for larger tumours, and many centres 
do not perform routine imaging for size (USG) in large breast 
tumours. A good correlation was seen between intra-operative 
tumour size and the USG measurement in our patients. USG is 
an excellent investigative tool for dense breasts, deep-seated 
lesions, and to follow the response to chemotherapy. USG is 
also considered superior to mammography for pre-operative 
estimation of tumour size [10,19]. This is also our experience; 
USG is easy to use and expertise is available at our hospital. 
Hence, we did not include mammography as a measurement 
method in the present study. Despite these advantages, USG 
tends to underestimate the tumour size when compared with 
pathologic size (the 'gold standard') in most cases [8,9,19–21]. 
Bosch and colleagues found that USG is an accurate predictor 
of pathological size, and pathological size can be determined by 
size measured by ultrasound + 3 mm [19]. In our study, we 
found a mean difference of 3.48 mm, which is comparable, but 
our gold standard for comparison was considered to be the 
intra-operative size. Recently, a lot of interest has been created 
by the use of the contrast-enhanced USG. In comparison to 
conventional USG, it has been shown to be a more accurate 
measure for pre-operative tumour size in invasive ductal cancer 
of the breast [22,23]. 
Despite the importance of tumour size in staging, management, 
choice of operation and prognosis, the exact state of the 
specimen to be measured has not been standardized. Formalin 
processing has been shown to alter tumour dimensions in many 
solid organ cancers, including the breast [3–7,12–14]. The 
effect of this alteration, chiefly reduction in size, has been 
shown to have worrisome implications for analysis of the 
margins, especially in breast conserving surgery [12,14]. Yeap 
et al have shown that loss of margins due to fixation can be 
substantial enough to influence re-excision decisions. They 
have thus recommended suspension of the specimen during 
transport, as well as stressing the need for more guidelines for 
specimen handling, to minimize these errors [14,24]. From our 
data, treatment decisions were unlikely to be influenced by 
small errors in margins, as all were mastectomy specimens. 
Also, there were no reported 'close' margins however, as a 
larger percentage of our patients are expected to undergo 
breast-conserving therapy in the near future, these issues will 
be very relevant. Many authors have identified factors, which 
affect the variation in size after fixation, such as histology, 
manipulation of specimen and the size of the tumour itself. Due 
to similar stage and histology of almost all our patients, this 
variation could be expected to be minimal. A single study by 
Pritt et al also states that overnight fixation does not change the 
gross tumour size, as long as microscopic measurements are 
not considered for comparison [13]. There is thus controversy 
over selection of the 'actual' size for staging. Most previous 
studies have taken pathologic size as the gold standard. 
Formalin fixation of tissue specimens occurs in two phases. 
During the first phase, the fixative penetrates the tissue by 
diffusion and accumulates to a sufficient concentration. In the 
second phase, formalin exhibits a gelling action and chemically 
binds to protein amino groups, eventually leading to extensive 
cross-links between proteins or between proteins and nucleic 
acids [25,26]. Although formalin is used to stabilize and 
preserve tissue ultrastructure, it occasionally causes distortion, 
vacuolization and cell shrinkage. These reactions not only affect 
tissue histochemical reactivity but also possibly cause gross 
change in specimen shape and size. Delayed fixation (>30 
minutes) increases proteolytic degradation and may affect 
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tumour-size measurement. The fixation duration also has an 
effect. Short fixation times have an effect only at the periphery 
of the tissue block, whereas prolonged fixation (>24 to 48 hours) 
leads to excessive structural changes. Many studies have 
documented this from time to time. In our patients, the duration 
of the specimen in formalin ranged from 14–20 hours. 
In two other similar studies carried out in breast carcinoma 
[9,14], all the measurements were recorded by the pathologist. 
This may be technically sound, but it may bring in some 
observer bias. In our hospital, the laboratory receives a large 
number of specimens, and the pathologist is unable to measure 
each specimen prior to fixation. For these reasons, we recruited 
three constant teams (surgeon, radiologist and pathologist) to 
minimize the observer variability. Both the previous studies 
have reported a discrepancy of only 1–2 mm in intra-operative 
and pathological tumour size, but even so in only a few patients. 
On the other hand, in our study, we found a mean difference of 
0.44 cm in 75.86% of patients. The reasons behind this may be 
the greater delay in fixation, delay in measurement after fixation 
(prolonged fixation) or measurement by different persons (the 
surgeon and the pathologist). This study may thus serve as a 
pilot study to a larger study, which could include all types of 
tumour excisions and follow standard guidelines for specimen 
processing. 
Estimation of the accurate tumour size by deriving formulae 
from other modalities of tumour size estimation (e.g. estimation 
of pathological tumour size from that measured from USG) has 
been attempted by a few workers previously [19]. The equations 
that we have derived may also be useful, provided that they are 
validated by a larger amount of data. 
 
Conclusions 
The tumour-size measurement is affected by factors such as 
specimen handling, delay in tumour fixation, duration of formalin 
fixation. Keeping in mind the great importance of tumour size in 
the management of breast cancer, the protocols used to 
measure size should be standardized to minimize chances of 
error in measurements and to bring uniformity in data analysis. 
Current data suggests that immediate fixation and 6–8 hours of 
formalin immersion does not affect the tumour size 
measurement. Larger studies are required to validate this 
conclusion.  
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